Policy HER2-positive metastatic breast cancer drug Tukysa approved by Lee, Hye-Kyung Dec 15, 2023 05:51am
Policy Non-inferior drugs likely to receive preferential pricing by Lee, Tak-Sun Dec 15, 2023 05:51am
Policy Will Enhertu be reimbursed using flexible ICER threshold? by Lee, Tak-Sun Dec 14, 2023 05:47am
Policy Only CKD and Jeil have high-dose Xeljanz generics approved by Lee, Hye-Kyung Dec 13, 2023 05:38am
Policy MOHW agrees to review current prior authorization system by Lee, Jeong-Hwan Dec 12, 2023 05:38am
Policy Pfizer conducts trial for its RSV drug sisunatovir in KOR by Lee, Hye-Kyung Dec 11, 2023 05:02am
Policy HIRA’s reimb reevaluation results to be released on the 7th by Lee, Tak-Sun Dec 7, 2023 05:47am